$36.98
0.932.58%
al cierre: -
$37.49
0.511.37%
After hour: Nov 14, 7:59 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Hims & Hers Health Inc tiene un precio objetivo de consenso de $31.94 basado en las calificaciones de 19 analistas. El máximo es $85, emitido por BTIG el noviembre 4, 2025. El mínimo es $10, emitido por Baird el abril 11, 2023. Las 3 calificaciones de analistas más recientes fueron publicadas por B of A Securities, BTIG y Canaccord Genuity el noviembre 4, 2025, noviembre 4, 2025 y septiembre 12, 2025, respectivamente. Con un precio objetivo promedio de $61.67 entre B of A Securities, BTIG y Canaccord Genuity, hay una 64.50% upside implícita para Hims & Hers Health Inc según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
B of A Securities
BTIG
Canaccord Genuity
Truist Securities
Morgan Stanley
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Hims & Hers Health
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/04/2025 | -14.64% | B of A Securities | $28 → $32 | Maintains | Underperform | |||
11/04/2025 | 126.74% | BTIG | $85 → $85 | Reiterates | Buy → Buy | |||
10/21/2025 | — | Keybanc | — | Initiates | → Sector Weight | |||
09/12/2025 | 81.39% | Canaccord Genuity | $68 → $68 | Maintains | Buy | |||
08/18/2025 | -1.3% | Truist Securities | $48 → $37 | Maintains | Hold | |||
08/05/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
07/17/2025 | 28.04% | Truist Securities | $45 → $48 | Maintains | Hold | |||
06/11/2025 | 6.7% | Morgan Stanley | $40 → $40 | Reiterates | Equal-Weight → Equal-Weight | |||
06/04/2025 | 73.39% | Needham | $61 → $65 | Maintains | Buy | |||
05/06/2025 | 4.03% | Piper Sandler | $35 → $39 | Reiterates | Neutral → Neutral | |||
05/06/2025 | -19.98% | Citigroup | $25 → $30 | Maintains | Sell | |||
05/06/2025 | 62.72% | Needham | $61 → $61 | Reiterates | Buy → Buy | |||
04/29/2025 | -30.65% | B of A Securities | $22 → $26 | Maintains | Underperform | |||
04/29/2025 | 6.7% | Morgan Stanley | $60 → $40 | Maintains | Equal-Weight | |||
04/29/2025 | -19.98% | TD Cowen | $44 → $30 | Downgrade | Buy → Hold | |||
04/25/2025 | -33.31% | Citigroup | $27 → $25 | Maintains | Sell | |||
04/10/2025 | -11.97% | Truist Securities | $39 → $33 | Maintains | Hold | |||
03/18/2025 | -41.32% | B of A Securities | $21 → $22 | Maintains | Underperform | |||
03/06/2025 | -43.98% | B of A Securities | $21 → $21 | Reiterates | Underperform → Underperform | |||
03/06/2025 | -27.98% | Citigroup | $27 → $27 | Reiterates | Sell → Sell | |||
02/26/2025 | 4.03% | Truist Securities | $24 → $39 | Maintains | Hold | |||
02/25/2025 | 6.7% | Leerink Partners | $24 → $40 | Maintains | Market Perform | |||
02/25/2025 | -6.64% | Piper Sandler | $24 → $35 | Maintains | Neutral | |||
02/25/2025 | 62.72% | Needham | $31 → $61 | Maintains | Buy | |||
02/25/2025 | -27.98% | Citigroup | $25 → $27 | Maintains | Sell | |||
02/20/2025 | -43.98% | B of A Securities | $18 → $21 | Maintains | Underperform | |||
02/19/2025 | 81.39% | Canaccord Genuity | $38 → $68 | Maintains | Buy | |||
02/18/2025 | 60.05% | Morgan Stanley | $42 → $60 | Downgrade | Overweight → Equal-Weight | |||
01/10/2025 | -33.31% | Citigroup | $24 → $25 | Downgrade | Neutral → Sell | |||
01/07/2025 | -6.64% | BTIG | → $35 | Initiates | → Buy | |||
01/06/2025 | -35.98% | Piper Sandler | $21 → $24 | Maintains | Neutral | |||
01/06/2025 | -17.31% | Needham | $28 → $31 | Maintains | Buy | |||
12/17/2024 | 12.03% | Morgan Stanley | → $42 | Initiates | → Overweight | |||
12/02/2024 | 1.36% | Canaccord Genuity | $28 → $38 | Maintains | Buy | |||
11/20/2024 | -25.31% | TD Cowen | $28 → $28 | Reiterates | Buy → Buy | |||
11/14/2024 | -51.99% | B of A Securities | $32 → $18 | Downgrade | Buy → Underperform | |||
11/08/2024 | -25.31% | TD Cowen | $25 → $28 | Maintains | Buy | |||
11/06/2024 | -27.98% | Deutsche Bank | $23 → $27 | Maintains | Hold | |||
11/05/2024 | -43.98% | Piper Sandler | $18 → $21 | Reiterates | Neutral → Neutral | |||
11/05/2024 | -25.31% | Canaccord Genuity | $24 → $28 | Maintains | Buy | |||
10/21/2024 | -33.31% | B of A Securities | $23 → $25 | Maintains | Buy | |||
10/14/2024 | -38.65% | B of A Securities | $20 → $23 | Maintains | Buy | |||
09/13/2024 | -46.65% | B of A Securities | $24 → $20 | Maintains | Buy | |||
08/22/2024 | -35.98% | Needham | → $24 | Initiates | → Buy | |||
08/07/2024 | -38.65% | Deutsche Bank | $16 → $23 | Maintains | Hold | |||
08/06/2024 | -51.99% | Piper Sandler | $18 → $18 | Reiterates | Neutral → Neutral | |||
07/18/2024 | -38.65% | Truist Securities | $13 → $23 | Maintains | Hold | |||
07/11/2024 | -33.31% | TD Cowen | $15 → $25 | Maintains | Buy | |||
07/11/2024 | -51.99% | Piper Sandler | $16 → $18 | Maintains | Neutral | |||
06/27/2024 | -38.65% | Jefferies | $14 → $23 | Maintains | Hold | |||
06/13/2024 | -30.65% | B of A Securities | $22 → $26 | Maintains | Buy | |||
06/03/2024 | -41.32% | B of A Securities | $17.25 → $22 | Maintains | Buy | |||
05/22/2024 | -35.98% | Canaccord Genuity | $20 → $24 | Maintains | Buy | |||
05/22/2024 | -46.65% | Citigroup | $16 → $20 | Downgrade | Buy → Neutral | |||
05/07/2024 | -57.32% | Deutsche Bank | $14 → $16 | Maintains | Hold | |||
05/07/2024 | -65.32% | Piper Sandler | $11 → $13 | Maintains | Neutral | |||
04/16/2024 | -59.99% | Jefferies | $17 → $15 | Downgrade | Buy → Hold | |||
04/10/2024 | -46.65% | Canaccord Genuity | → $20 | Initiates | → Buy | |||
02/27/2024 | -54.65% | Guggenheim | $15 → $17 | Maintains | Buy | |||
02/27/2024 | -57.32% | Citigroup | $12 → $16 | Maintains | Buy | |||
02/27/2024 | -70.66% | Piper Sandler | $9 → $11 | Maintains | Neutral | |||
02/27/2024 | -65.32% | Truist Securities | $10 → $13 | Maintains | Hold | |||
02/26/2024 | -73.33% | Leerink Partners | → $10 | Initiates | → Market Perform | |||
01/05/2024 | -59.99% | Tigress Financial | $14 → $15 | Maintains | Buy | |||
08/09/2023 | -73.33% | Truist Securities | $12 → $10 | Maintains | Hold | |||
08/08/2023 | -62.66% | Credit Suisse | → $14 | Reiterates | Outperform → Outperform | |||
07/28/2023 | -70.66% | TD Cowen | → $11 | Initiates | → Outperform | |||
06/15/2023 | -62.66% | Tigress Financial | $12 → $14 | Reiterates | → Buy | |||
05/30/2023 | -70.66% | Piper Sandler | $12 → $11 | Maintains | Neutral | |||
05/09/2023 | -59.99% | B of A Securities | $13.5 → $15 | Maintains | Buy | |||
05/09/2023 | -67.99% | Piper Sandler | $11 → $12 | Maintains | Neutral | |||
04/27/2023 | -51.99% | Guggenheim | $15 → $18 | Maintains | Buy | |||
04/26/2023 | -70.66% | Piper Sandler | $10 → $11 | Maintains | Neutral | |||
04/11/2023 | -73.33% | Baird | → $10 | Initiates | → Neutral | |||
03/01/2023 | -62.66% | Credit Suisse | $8 → $14 | Maintains | Outperform | |||
02/28/2023 | -59.99% | Guggenheim | → $15 | Reiterates | → Buy | |||
02/28/2023 | -67.99% | Truist Securities | $7 → $12 | Maintains | Hold | |||
02/28/2023 | -62.66% | Citigroup | $9 → $14 | Maintains | Buy | |||
02/28/2023 | -73.33% | Piper Sandler | $7 → $10 | Maintains | Neutral | |||
02/28/2023 | -63.99% | B of A Securities | $11.5 → $13.5 | Maintains | Buy | |||
02/09/2023 | -70.66% | Jefferies | $7 → $11 | Upgrade | Hold → Buy | |||
01/12/2023 | -67.99% | Tigress Financial | $11 → $12 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Hims & Hers Health (HIMS)?
El último precio objetivo de Hims & Hers Health (NYSE:HIMS) fue comunicado por B of A Securities el noviembre 4, 2025. La firma de analistas fijó un precio objetivo para $32.00 que espera HIMS a fall dentro de 12 meses (un posible -14.64% downside). 35 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Hims & Hers Health (HIMS)?
La última calificación de analistas para Hims & Hers Health (NYSE:HIMS) fue proporcionada por B of A Securities, y Hims & Hers Health mantuvo su underperform calificación.
¿Cuándo se produjo la última revisión al alza de Hims & Hers Health (HIMS)?
La última revisión al alza de Hims & Hers Health Inc se produjo en febrero 9, 2023, cuando Jefferies elevó su precio objetivo a $11. Jefferies anteriormente tenía a hold para Hims & Hers Health Inc.
¿Cuándo fue la última revisión a la baja de Hims & Hers Health (HIMS)?
La última revisión a la baja de Hims & Hers Health Inc se produjo en abril 29, 2025, cuando TD Cowen cambió su precio objetivo de $44 a $30 para Hims & Hers Health Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Hims & Hers Health (HIMS)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Hims & Hers Health, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Hims & Hers Health se registró el noviembre 4, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 4, 2026.
¿Es correcta la calificación de los analistas sobre Hims & Hers Health (HIMS)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Hims & Hers Health (HIMS) fue un mantuvo con un precio objetivo de $28.00 a $32.00. El precio actual al que cotiza Hims & Hers Health (HIMS) es de $37.49, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.